HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers

Published:2019-09-12 Issue:8 Volume:56 Page:533-566
ISSN:1040-8363
Container-title:Critical Reviews in Clinical Laboratory Sciences
language:en
Short-container-title:Critical Reviews in Clinical Laboratory Sciences

Author:

Moosavi Fatemeh¹^ORCID,Giovannetti Elisa²³^ORCID,Saso Luciano⁴^ORCID,Firuzi Omidreza¹^ORCID

Affiliation:

1. Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;

2. Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VU University Medical Center (VUmc), Amsterdam, The Netherlands;

3. Cancer Pharmacology Lab, AIRC Start Up Unit, Fondazione Pisana per la Scienza Onlus, Pisa, Italy;

4. Department of Physiology and Pharmacology, “Vittorio Erspamer,” Sapienza University, Rome, Italy

Publisher

Informa UK Limited

Subject

Biochemistry (medical),Clinical Biochemistry,General Biochemistry, Genetics and Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10408363.2019.1653821

Reference247 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015

3. Global cancer statistics, 2012

4. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

5. Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer;Gene;2024-02

2. From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy;Histochemistry and Cell Biology;2024-01-08

3. MET alterations detection platforms and clinical implications in solid tumors: a comprehensive review of literature;Therapeutic Advances in Medical Oncology;2024-01

4. Development of a contacting transwell co-culture system for the in vitro propagation of primary central nervous system lymphoma;Frontiers in Cell and Developmental Biology;2023-11-27

5. A novel prognostic classification integrating lipid metabolism and immune co-related genes in acute myeloid leukemia;Frontiers in Immunology;2023-11-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3